期刊
JOURNAL OF MEDICAL GENETICS
卷 49, 期 3, 页码 179-183出版社
B M J PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2011-100542
关键词
-
资金
- Consortium 'Stronger on your own feet'
- MHW, The Netherlands Organization for Health Research and Development (ZonMw) [916-86-016, 917-66-363, 911-08-025, 917-86-319, 907-00-365]
- EU [Health-F5-2009-223143, 241995]
- AnEuploidy project [LSHG-CT-2006-37627]
- GENCODYS
Background DYNC1H1 encodes the heavy chain protein of the cytoplasmic dynein 1 motor protein complex that plays a key role in retrograde axonal transport in neurons. Furthermore, it interacts with the LIS1 gene of which haploinsufficiency causes a severe neuronal migration disorder in humans, known as classical lissencephaly or Miller-Dieker syndrome. Aim To describe the clinical spectrum and molecular characteristics of DYNC1H1 mutations. Methods A family based exome sequencing approach was used to identify de novo mutations in patients with severe intellectual disability. Results In this report the identification of two de novo missense mutations in DYNC1H1 (p.Glu1518Lys and p.His3822Pro) in two patients with severe intellectual disability and variable neuronal migration defects is described. Conclusion Since an autosomal dominant mutation in DYNC1H1 was previously identified in a family with the axonal (type 2) form of Charcot-Marie-Tooth (CMT2) disease and mutations in Dync1h1 in mice also cause impaired neuronal migration in addition to neuropathy, these data together suggest that mutations in DYNC1H1 can lead to a broad phenotypic spectrum and confirm the importance of DYNC1H1 in both central and peripheral neuronal functions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据